726 related articles for article (PubMed ID: 17264097)
21. [Iron supplementation during erythropoietin therapy in patients on hemodialysis].
Svára F; Sulková S; Kvasnićka J; Polakovic V
Vnitr Lek; 1996 Dec; 42(12):849-52. PubMed ID: 9072885
[TBL] [Abstract][Full Text] [Related]
22. Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress.
Swarnalatha G; Ram R; Neela P; Naidu MU; Dakshina Murty KV
Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):852-8. PubMed ID: 20814119
[TBL] [Abstract][Full Text] [Related]
23. Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients.
Fujita N; Horiike S; Sugimoto R; Tanaka H; Iwasa M; Kobayashi Y; Hasegawa K; Ma N; Kawanishi S; Adachi Y; Kaito M
Free Radic Biol Med; 2007 Feb; 42(3):353-62. PubMed ID: 17210448
[TBL] [Abstract][Full Text] [Related]
24. Melatonin corrects reticuloendothelial blockade and iron status in haemodialysed patients.
Labonia W; Rubio D; Arias C
Nephrology (Carlton); 2005 Dec; 10(6):583-7. PubMed ID: 16354241
[TBL] [Abstract][Full Text] [Related]
25. Comparison of oral versus intravenous iron therapy in predialysis patients of chronic renal failure receiving recombinant human erythropoietin.
Aggarwal HK; Nand N; Singh S; Singh M; Hemant ; Kaushik G
J Assoc Physicians India; 2003 Feb; 51():170-4. PubMed ID: 12725261
[TBL] [Abstract][Full Text] [Related]
26. Comparative response to single or divided doses of parenteral iron for functional iron deficiency in hemodialysis patients receiving erythropoietin (EPO).
Saltissi D; Sauvage D; Westhuyzen J
Clin Nephrol; 1998 Jan; 49(1):45-8. PubMed ID: 9491286
[TBL] [Abstract][Full Text] [Related]
27. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
Coronel F; Herrero JA; Montenegro J; Fernandez C; Gandara A; Conesa J; Rivera MT; Torrente J; Portolés J; Gomez-Martino JR
J Nephrol; 2003; 16(5):697-702. PubMed ID: 14733416
[TBL] [Abstract][Full Text] [Related]
28. Serum ferritin in chronic kidney disease: reconsidering the upper limit for iron treatment.
Fishbane S; Kalantar-Zadeh K; Nissenson AR
Semin Dial; 2004; 17(5):336-41. PubMed ID: 15461737
[TBL] [Abstract][Full Text] [Related]
29. Long-term erythropoietin therapy does not affect endothelial markers, coagulation activation and oxidative stress in haemodialyzed patients.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2007; 120(6):797-803. PubMed ID: 17391740
[TBL] [Abstract][Full Text] [Related]
30. Comparison of a statin vs. hypolipemic diet on the oxidant status in hemodialyzed patients with chronic renal failure.
Mastalerz-Migas A; Reksa D; Pokorski M; Steciwko A; Muszyńska A; Bunio A; Drobnik J; Pokorna-Kałwak D
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):363-70. PubMed ID: 18204148
[TBL] [Abstract][Full Text] [Related]
31. Intravenous iron dextran treatment in predialysis patients with chronic renal failure.
Dahdah K; Patrie JT; Bolton WK
Am J Kidney Dis; 2000 Oct; 36(4):775-82. PubMed ID: 11007680
[TBL] [Abstract][Full Text] [Related]
32. Monitoring iron status in end-stage renal disease patients on hemodialysis.
Rafi A; Karkar A; Abdelrahman M
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
[TBL] [Abstract][Full Text] [Related]
33. High iron storage levels are associated with increased DNA oxidative injury in patients on regular hemodialysis.
Yoshimura K; Nakano H; Yokoyama K; Nakayama M
Clin Exp Nephrol; 2005 Jun; 9(2):158-63. PubMed ID: 15980952
[TBL] [Abstract][Full Text] [Related]
34. Total dose infusion of intravenous iron in patients with chronic kidney disease receiving haemodialysis.
Fenwick S; Peebles G
J Ren Care; 2011 Mar; 37(1):47-51. PubMed ID: 21288317
[TBL] [Abstract][Full Text] [Related]
35. Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia.
Marsillach J; Martínez-Vea A; Marcas L; Mackness B; Mackness M; Ferré N; Joven J; Camps J
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):347-9. PubMed ID: 17324148
[TBL] [Abstract][Full Text] [Related]
36. Nononcologic use of human recombinant erythropoietin therapy in hospitalized patients.
Fischer MA; Morris CA; Winkelmayer WC; Avorn J
Arch Intern Med; 2007 Apr; 167(8):840-6. PubMed ID: 17452549
[TBL] [Abstract][Full Text] [Related]
37. Upper limit of serum ferritin: misinterpretation of the 2006 KDOQI anemia guidelines.
Fishbane S
Semin Dial; 2008; 21(3):217-20. PubMed ID: 18248518
[TBL] [Abstract][Full Text] [Related]
38. Effects of hemodialysis, dialyser type and iron infusion on oxidative stress in uremic patients.
Müller C; Eisenbrand G; Gradinger M; Rath T; Albert FW; Vienken J; Singh R; Farmer PB; Stockis JP; Janzowski C
Free Radic Res; 2004 Oct; 38(10):1093-100. PubMed ID: 15512797
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of reticulocyte haemoglobin content as marker of iron deficiency and predictor of response to intravenous iron in haemodialysis patients.
Kim JM; Ihm CH; Kim HJ
Int J Lab Hematol; 2008 Feb; 30(1):46-52. PubMed ID: 18190467
[TBL] [Abstract][Full Text] [Related]
40. Effect of iron loading on peripheral blood lymphocyte subsets and on circulating cytokine levels in iron-depleted hemodialysis patients receiving erythropoietin.
Tsouchnikas I; Tsilipakou M; Daniilidis M; Kyriazis G; Pasadakis P; Parapanissiou E; Vargemezis V; Tsakiris D
Nephron Clin Pract; 2007; 107(3):c97-102. PubMed ID: 17890877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
